Mesoporous silica nanoparticles with co-condensed gadolinium chelates for multimodal imaging

Nanomaterials

Volumn 2, Issue 1, 2012, Pages

  Taylor Pashow, Kathryn M L ^a   Della Rocca, Joseph ^b   Lin, Wenbin ^b  

^a SAVANNAH RIVER NATIONAL LABORATORY   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

Author keywords

Gd3+ multimodal imaging contrast agent; Mesoporous silica nanoparticle; MRI contrast agent

Indexed keywords

EID: 85117870677     PISSN: None     EISSN: 20794991     Source Type: Journal    
DOI: 10.3390/nano2010001     Document Type: Article

References (43)

1. Stark, D.; Bradley, W.G., Jr. Magnetic Resonance Imaging; Mosby: St. Louis, MO, USA, 1999.
2. Toth, E.; Helm, L.; Merbach, A.E. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging; John Wiley and Sons: Chichester, UK, 2001.
3. Caravan, P.; Ellison, J.J.; McMurry, T.J.; Lauffer, R.B. Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications. Chem. Rev. 1999, 99, 2293-2352.
4. Kim, J.; Piao, Y.; Hyeon, T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem. Soc. Rev. 2009, 28, 372–390.
5. Lin, W.; Hyeon, T.; Lanza, G.; Miqin, M.Z.; Meade, T.J. Magnetic nanoparticles for early detection of cancer by magnetic resonance imaging. MRS Bull. 2009, 34, 441–448.
6. Weissleder, R.; Moore, A.; Mahmood, U.; Bhorade, R.; Benveniste, H.; Chiocca, E.A.; Basilion, J.P. In vivo magnetic resonance imaging of transgene expression. Nat. Med. 2000, 6, 351–354.
7. Morawski, A.M.; Lanza, G.M.; Wickline, S.A. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr. Opin. Biotechnol. 2005, 16, 89–92.
8. Frias, J.C.; Ma, Y.; Williams, K.J.; Fayad, Z.A.; Fisher, E.A. Properties of a versatile nanoparticle platform contrast agent to image and characterize atherosclerotic plaques by magnetic resonance imaging. Nano Lett. 2006, 6, 2220–2224
9. Rieter, W.J.; Taylor, K.M.L.; An, H.; Lin, W.; Lin, W. Nanoscale metal organic frameworks as potential multimodal contrast agents. J. Am. Chem. Soc. 2006, 128, 9024–9025.
10. III-functionalized fluorescent quantum dots as multimodal imaging probes. Adv. Mater. 2006, 18, 2890–2894.
11. Rieter, W.J.; Kim, J.S.; Taylor, K.M.L.; An, H.; Lin, W.; Tarrant, T.; Lin, W. Hybrid silica nanoparticles for multimodal imaging. Angew. Chem. Int. Ed. 2007, 46, 3680–3682.
12. Kim, J.S.; Rieter, W.J.; Taylor, K.M.L.; An, H.; Lin, W.; Lin, W. Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging. J. Am. Chem. Soc. 2007, 129, 8962–8963.
13. Taylor, K.M.L.; Jin, A.; Lin, W. Surfactant-assisted synthesis of nanoscale gadolinium metal organic frameworks for potential multimodal imaging. Angew. Chem. Int. Ed. 2009, 47, 7722–7725.
14. Zhang, H.; Zhang, L.; Myerson, J.; Bibee, K.; Scott, M.; Allen, J.; Sicard, G.; Lanza, G.; Wickline, S.A. Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents. PLoS One 2011, 6, 0026385.
15. Huang, R.; Han, L.; Liu, S.; Shao, K.; Kuang, Y.; Hu, X.; Wang, X.; Lei, H.; Jiang, C. Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis. Biomaterials 2011, 32, 5177–5186.
16. Liu, Y.; Chen, Z.; Yu, D.; Lu, Z.; Zhang, N. Gadolinium-Loaded Polymeric Nanoparticles Modified with Anti-VEGF as multifunctional MRI contrast agents for the diagnosis of liver cancer. Biomaterials 2011, 32, 5167–5186.
17. Yang, H.; Zhuang, Y.; Sun, Y.; Dai, A.; Shi, X.; Wu, D.; Li, F.; Hu, H.; Yang, S. Targeted dual-contrast T1-and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials 2011, 32, 4584–4593.
18. Hatakeyama, W.; Sanchez, T.J.; Rowe, M.D.; Serkova, N.J.; Liberatore, M.W.; Boyes, S.G. Synthesis of gadolinium nanoscale metal-organic framework with hydrotropes: Manipulation of particle size and magnetic resonance imaging capability. ACS Appl. Mater. Interfaces 2011, 3, 1502–1510.
19. Ghaghada, K.B.; Ravoori, M.; Sabapathy, D.; Bankson, J.; Kundra, V.; Annapraga, A. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PLoS One 2009, 4, e7628.
20. Beck, J.S.; Vartuli, J.C.; Roth, W.J.; Leonowicz, M.E.; Kresge, C.T.; Schmitt, K.D.; Chu, C.T.-W.; Olson, D.H.; Sheppard, E.W.; McCullen, S.B.; Higgins, J.B.; Schlenker, J.L. A new family of mesoporous molecular sieves prepared with liquid crystal templates. J. Am. Chem. Soc. 1992, 114, 10834–10843.
21. Kresge, C.T.; Leonowicz, M.E.; Roth, W.J.; Vartuli, J.C.; Beck, J.S. Ordered mesoporous molecular sieves synthesized by a liquid-crystal template mechanism. Nature 1992, 359, 710–712.
22. Cai, Q.; Luo, Z.-S.; Pang, W.-Q.; Fan, Y.-W.; Chen, X.-H.; Cui, F.-Z. Dilute solution routes to various controllable morphologies of MCM-41 silica with a basic medium. Chem. Mater. 2001, 13, 258–263.
23. Grun, M.; Unger, K.K.; Matsumoto, A.; Tsutsumi, K. Novel pathways for the preparation of mesoporous MCM-41 materials: Control of porosity and morphology. Microporous Mesoporous Mater. 1999, 27, 207–216.
24. Lu, F.; Wu, S.-H.; Hung, Y.; Mou, C.-Y. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles. Small 2009, 5, 1408–1413.
25. Urata, C.; Aoyama, Y.; Tonegawa, A.; Yamauchi, Y.; Kuroda, K. Dialysis process for the removal of surfactants to form colloidal mesoporous silica nanoparticles. Chem. Commun. 2009, 5094–5096.
26. Lin, Y.-S.; Abadeer, N.; Haynes, C.L. Stability of small mesoporous silica nanoparticles in biological media. Chem. Commun. 2010, 47, 532–534.
27. Ge, J.; Zhang, Q.; Zhang, T.; Yin, Y. Core-satellite nanocomposite catalysts protected by a porous silica shell: Controllable reactivity, high stability, and magnetic recyclability. Angew. Chem. Int. Ed. 2008, 47, 8924–8928.
28. Chen, H.-T.; Huh, S.; Wiench, J.W.; Pruski, M.; Lin, V.S.-Y. Dialkylaminopyridine-functionalized mesoporous silica nanosphere as an efficent and highly stable heterogeneous nucleophillic catalyst. J. Am. Chem. Soc. 2005, 127, 13305–13311.
29. Mihalcik, D.J.; Lin, W. Mesoporous silica nanosphere supported ruthenium catalysts for asymmetric hydrogenation. Angew. Chem. Int. Ed. 2008, 47, 6229–6232.
30. 2 nanofibers and covered by porous silica. Angew. Chem. Int. Ed. 2010, 49, 8165–8168.
31. Liong, M.; Liu, J.; Kovochich, M.; Xia, T.; Ruehm, S.G.; Nel, A.E.; Tamanoi, F.; Zink, J.I. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2, 889–896.
32. Ambrogio, M.W.; Thomas, C.R.; Zhao, Y.L.; Zink, J.I.; Stoddart, J.F. Mechanized silica nanoparticles: A new frontier in theranostic nanomedicine. Acc. Chem. Res. 2011, 44, 903–913.
33. Ashley, C.E.; Carnes, E.C.; Phillips, G.K.; Padilla, D.; Durfee, P.N.; Brown, P.A.; Hanna, T.N.; Liu, J.; Phillips, B.; Carter, M.B.; et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat. Mater. 2011, 10, 389–397.
34. Liu, J.; Stace-Naughton, A.; Jiang, X.; Brinker, C.J. Porous nanoparticle supported lipid bilayers (protocells) as delivery vehicles. J. Am. Chem. Soc. 2009, 131, 1354–1355.
35. Slowing, I.; Trewyn, B.G.; Lin, V.S.-Y. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 2006, 128, 14792–14793.
36. Slowing, I.; Trewyn, B.G.; Lin, V.S.-Y. Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J. Am. Chem. Soc. 2007, 129, 8845–8849.
37. Liu, R.; Liao, P.; Liu, J.; Feng, P. Responsive polymer-coated mesoporous silica as a pH-sensitive nanocarrier for controlled release. Langmuir 2011, 27, 3095–3099.
38. Liu, R.; Zhang, Y.; Feng, P. Multiresponsive supramolecular nanogated ensembles. J. Am. Chem. Soc. 2009, 131, 15128–15129.
39. Taylor-Pashow, K.M.L.; Della Rocca, J.; Huxford, R.C.; Lin, W. Hybrid nanomaterials ffor biomedical applications. Chem. Commun. 2010, 46, 5832–5849.
40. Taylor, K.M.L.; Kim, J.S.; Rieter, W.J.; An, H.; Lin, W.; Lin, W. Mesoporous silica nanospheres as highly efficent MRI contrast agents. J. Am. Chem. Soc. 2008, 130, 2154–2155.
41. Huh, S.; Wiench, J.W.; Trewyn, B.G.; Song, S.; Pruski, M.; Lin, V.S.-Y. Tuning of particle morphology and pore properties in mesoporous silicas with multiple functional groups. Chem. Commun. 2003, 2364–2365.
42. Huh, S.; Wiench, J.W.; Yoo, J.-C.; Pruski, M.; Lin, V.S.-Y. Organic functionalization and morphology control of mesoporous silicas via a Co-condensation synthesis method. Chem. Mater. 2003, 15, 4247–4256.
43. Temming, K.; Schiffelers, R.M.; Molema, G.; Kok, R.J. RGD-based strategies for selective delivery of therapuetics and imaging agents to the tumour vasculature. Drug Resist. Updat. 2005, 8, 381–402.